To study the function of endogenous MYC in PDAC cells, we expressed shRNAs targeting MYC in cells that have been derived from a tumor arising in the KPC mouse model driven by KRAS and p53 mutations (Fig. 1a)5,7. This evidence concerns the gene KRAS and neoplasm.